financetom
Business
financetom
/
Business
/
Docusign Stock Rises On Q4 Earnings Beat, Strong Guidance, Bigger Buyback
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Docusign Stock Rises On Q4 Earnings Beat, Strong Guidance, Bigger Buyback
Mar 17, 2026 2:03 PM

Docusign Inc ( DOCU ) delivered its fourth-quarter financial results on Tuesday after the market close. Here’s everything you need to know from the report.

Docusign ( DOCU ) stock is showing upward movement. Why is DOCU stock advancing?

Key Highlights From Q4

Docusign ( DOCU ) posted fourth-quarter revenue of $836.86 million, beating the consensus estimate of $827.84 million. The agreement management company reported adjusted earnings of $1.01 per share for the quarter, beating analyst estimates of 95 cents per share, according to Benzinga Pro.

Total revenue was up 8% year-over-year, driven by subscription revenue growth, which was up 8% year-over-year to $819 million. Professional services and other revenue decreased 3% year-over-year to $17.9 million.

Billings came in at approximately $1 billion, up 10% year-over-year. Net cash from operating activities totaled $377.2 million. The company generated free cash flow of $350.2 million in the quarter.

“Docusign’s AI-native IAM platform has established clear market leadership as the agreement system of action for companies of all sizes,” said Allan Thygesen, CEO of Docusign ( DOCU ). “In 2026, customers using IAM represented over $350 million in ARR, and Docusign ( DOCU ) reached record highs for operating margin and free cash flow.”

Docusign ( DOCU ) said it repurchased $269.1 million of its common stock during the fourth quarter. The company ended the period with approximately $1.1 billion in cash, cash equivalents and investments.

Docusign ( DOCU ) announced that its board authorized an increase of up to $2 billion to its existing buyback, bringing total authorized share repurchases up to $2.6 billion.

What’s Next For Docusign?

Docusign ( DOCU ) expects first-quarter revenue to be in the range of $822 million to $826 million versus estimates of $813.34 million. The company also introduced guidance for fiscal 2027. Docusign ( DOCU ) anticipates full-year revenue in the range of approximately $3.48 billion to $3.50 billion versus estimates of $3.42 billion.

Andreessen Horowitz general partner Brian Roberts has joined Docusign’s board. Roberts previously served as CFO of Splunk and Lyft and joined Andreessen Horowitz in 2024.

Docusign ( DOCU ) executives will discuss the quarter on an earnings call scheduled to start at 5 p.m. ET.

DOCU Shares Climb After Q4 Report

DOCU Price Action: Docusign ( DOCU ) shares were up 1.87% in after-hours, trading at $48.43 at the time of publication on Tuesday, according to Benzinga Pro.

Image: Shutterstock.com

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Ocugen Signs Deal for Korean Rights to Gene Therapy OCU400
Ocugen Signs Deal for Korean Rights to Gene Therapy OCU400
Jun 5, 2025
07:49 AM EDT, 06/05/2025 (MT Newswires) -- Ocugen ( OCGN ) said Thursday it signed a binding term sheet with a major South Korean pharmaceutical partner to negotiate and enter into a licensing agreement for its experimental gene therapy, OCU400, in Korea. Under the future agreement, Ocugen ( OCGN ) said it will receive up to $11 million in upfront...
Petroleo Brasileiro Eyes Expansion in West Africa With Interest in Ivory Coast Oil Blocks
Petroleo Brasileiro Eyes Expansion in West Africa With Interest in Ivory Coast Oil Blocks
Jun 5, 2025
07:48 AM EDT, 06/05/2025 (MT Newswires) -- Petroleo Brasileiro (PBR) said late Wednesday it submitted a declaration of interest for nine offshore exploratory blocks in the Ivory Coast. The company said the Ivorian government has approved the declaration, which grants Petrobras exclusivity to enter contractual negotiations, which is the next phase in the acquisition process. Petrobras' decision followed internal governance...
Aurora Cannabis Launches New Medical Cannabis Product in Australia
Aurora Cannabis Launches New Medical Cannabis Product in Australia
Jun 5, 2025
07:44 AM EDT, 06/05/2025 (MT Newswires) -- Aurora Cannabis ( ACB ) said Thursday it has expanded its IndiMed brand in Australia with the launch of IndiMed Tempo 22, available through its subsidiary, MedReleaf Australia. IndiMed remains one of the most prescribed medical cannabis brands for patients in Australia, Aurora said in a statement. Expanding our portfolio in the value...
Copyright 2023-2026 - www.financetom.com All Rights Reserved